Two-dimensional Silicene-based Technologies in Oncology: An Emerging Avenue

Abstract

Silicene, a two-dimensional allotrope of silicon, has attracted considerable attention due to its distinctive electronic, mechanical, and biochemical properties. This review critically examines the emerging applications of silicene in oncology, emphasising its potential roles in cancer therapy, and research. Silicene exhibits exceptional biocompatibility and surface reactivity positioning it as a promising candidate for oncological applications. This mini review addresses the current challenges and limitations in the clinical translation of silicene-based technologies, including issues of stability, toxicity, and scalable production. By synthesizing recent research findings, this review aims to provide an assessment of silicene's potential contributions to oncology and delineate future research trajectories in this innovative field.

Article information

Article type
Minireview
Submitted
31 Aug 2024
Accepted
20 Sep 2024
First published
26 Sep 2024

Nanoscale, 2024, Accepted Manuscript

Two-dimensional Silicene-based Technologies in Oncology: An Emerging Avenue

J. Sengupta and C. M. Hussain, Nanoscale, 2024, Accepted Manuscript , DOI: 10.1039/D4NR03565H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements